Company profile
Alaunos Therapeutics company profile
Alaunos Therapeutics is a biotechnology company employing a novel gene expression and control technology to deliver DNA for the treatment of cancer. ZIOPHARM's technology platform employs Intrexon Corporation's RheoSwitch Therapeutic System® to turn on and off and precisely modulate gene expression at the cancer site in order to improve the therapeutic index. This technology is currently being evaluated in Phase 2 clinical studies of the immune system cytokine interleukin-12 for the treatment of breast cancer and advanced melanoma. Multiple new INDs for new targets using similar technology are expected in 2014 and 2015. ZIOPHARM is also developing novel small molecules..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://alaunos.com/
- Contact email
- [email protected]
- Phone number
- 617-259-1970
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $0+
- Founded
- 2005-01-01
Headquarters
- Headquarters
- Troy, New Hampshire, United States
- Postal code
- 10036
- Country code
- US
- Continent
- North America